动脉过滤器市场机会、成长动力、产业趋势分析及 2025 - 2034 年预测

2024年，全球动脉过滤器市场规模达7.541亿美元，预估年复合成长率为7.1%，2034年将达15亿美元。市场扩张的主要驱动力包括心血管疾病发病率的上升、心胸外科手术数量的增加、过滤器设计的技术进步以及医疗保健投资的不断增长。对病人安全的高度重视以及严格手术方案的采用进一步推动了对动脉过滤器的需求。这些过滤器有助于减少体外循环中的栓塞併发症，其使用得到了美国食品药物管理局（FDA）和欧洲药品管理局（EMA）等监管机构的支持，确保其被纳入标准医疗实践。

动脉过滤器是体外循环 (CPB) 和体外膜氧合 (ECMO) 过程中必不可少的医疗器械，用于在血液返回患者动脉系统之前去除血液中的气泡、血块和微栓子。这些过滤器有助于降低栓塞和器官损伤的风险，这在心臟手术和其他重症监护手术中至关重要。随着产业的发展，过滤器设计的创新、向微创手术的转变以及生物相容性和血液相容性材料的进步正在推动动脉过滤器市场的扩张。客製化需求以及一次性过滤器解决方案的兴起进一步增强了市场的成长潜力。

聚丙烯市场预计将显着成长，复合年增长率达7%，到2034年将达到6.339亿美元。聚丙烯(PP)因其耐化学性和耐高温性而备受推崇，是体外循环等高压力环境的理想选择。其在不同温度下的稳定性以及良好的生物相容性确保其不会干扰人体的自然生理过程。该材料在体外循环过程中减少血栓形成和发炎的能力预计将推动该市场的成长。

预计100-200毫升过滤器市场的复合年增长率将达到6.9%，到2034年将达到8.692亿美元。这些过滤器在过滤效率和血液稀释之间实现了最佳平衡，适用于成人手术。它们有利于维持患者的血液容量，同时减少对捐赠者输血的需求。这些过滤器改进了微泡和排气功能，这对于维护患者安全和确保高手术标准至关重要。其设计最大限度地减少了血流阻力，进一步增强了其在心臟手术（尤其是成人手术）中的需求，而成人手术在全球心臟手术市场中占据主导地位。

2024年，美国动脉过滤器市场规模达2.765亿美元。美国先进的医疗保健体系和一流的外科手术基础设施使其成为动脉过滤器市场的关键参与者。训练有素的医务人员和大量复杂的心臟手术，推动了美国医院对动脉过滤器的持续需求，推动了市场的成长。

全球动脉过滤器市场的知名公司包括：美敦力 (Medtronic)、GETINGE、SENKO Medical Instrument、Braile Biomedica、颇尔 (Pall Corporation)、LivaNova、Lifeline Systems、EUROSETS、尼普罗 (NIPRO)、Gen World Medical Devices、TERUMO 和北京美多斯艾特生物科技有限公司。在动脉过滤器市场，各公司正在实施多项策略以提升其市场地位。他们专注于开发满足特定手术需求的先进客製化产品，使其产品脱颖而出。此外，许多公司正在投资研发可提高过滤器性能的材料，例如生物相容性和血液相容性材料，以满足对更安全、更有效设备日益增长的需求。与医院和医疗保健提供者的合作也至关重要，这使得製造商能够将其过滤器整合到标准的手术实践中。

目录

第一章：方法论与范围

第二章：执行摘要

第三章：行业洞察

• 产业生态系统分析
• 产业衝击力
  • 成长动力
    • 心血管疾病盛行率不断上升
    • 体外循环手术的增长
    • 过滤器设计的技术进步
    • 老年人口不断增加
  • 产业陷阱与挑战
    • 心臟手术和设备费用高昂
    • 过滤器併发症的风险
  • 市场机会
    • 下一代动脉过滤器的开发
    • 小儿和新生儿心臟外科手术的成长
• 成长潜力分析
• 监管格局
  • 我们
  • 欧洲
• 技术格局
• 未来市场趋势
• 差距分析
• 波特的分析
• PESTEL分析
• 未来市场趋势
• 价值链分析

第四章：竞争格局

• 介绍
• 公司矩阵分析
• 公司市占率分析
  • 按地区
    • 北美洲
    • 欧洲
    • 亚太地区
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 策略仪表板
• 关键进展
  • 併购
  • 伙伴关係和合作
  • 新产品发布
  • 扩张计划

第五章：市场估计与预测：按过滤材料，2021 - 2034 年

• 主要趋势
• 聚丙烯
• 聚乙烯
• 聚氯乙烯（PVC）
• 其他过滤材料

第六章：市场估计与预测：按启动量，2021 - 2034 年

• 主要趋势
• 少于100毫升
• 100–200 毫升
• 超过200毫升

第七章：市场估计与预测：按年龄组，2021 - 2034 年

• 主要趋势
• 成人
• 新生儿/儿科

第八章：市场估计与预测：按应用，2021 - 2034 年

• 主要趋势
• 体外循环（CPB）
• 体外膜氧合（ECMO）
• 其他应用

第九章：市场估计与预测：依最终用途，2021 - 2034 年

• 主要趋势
• 医院
• 门诊手术中心
• 其他最终用途

第十章：市场估计与预测：按地区，2021 - 2034 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：公司简介

• Beijing MEDOS AT Biotechnology
• Braile Biom'dica
• EUROSETS
• Gen World Medical Devices
• GETINGE
• Lifeline Systems
• LivaNova
• Medtronic
• NIPRO
• Pall Corporation
• SENKO Medical Instrument
• TERUMO

The Global Arterial Filter Market was valued at USD 754.1 million in 2024 and is estimated to grow at a CAGR of 7.1% to reach USD 1.5 billion by 2034. This market expansion is primarily driven by the rising incidence of cardiovascular diseases, the increasing number of cardiothoracic surgeries, technological advancements in filter designs, and growing healthcare investments. The heightened focus on patient safety and the adoption of strict surgical protocols further contribute to the demand for arterial filters. These filters help reduce embolic complications during extracorporeal circulation, and their use is supported by regulatory bodies like the FDA and EMA, ensuring their integration into standard medical practices.

Arterial filters are essential medical devices used during cardiopulmonary bypass (CPB) and extracorporeal membrane oxygenation (ECMO) to remove air bubbles, blood clots, and microemboli from the blood before it is returned to the patient's arterial system. These filters help reduce the risk of embolism and organ damage, which is crucial during cardiac surgeries and other critical care procedures. As the industry grows, innovations in filter design, the shift towards minimally invasive surgeries, and advancements in biocompatible and hemocompatible materials are fueling the expansion of the arterial filter market. The demand for customization, along with the rise of disposable filter solutions, further strengthens the market's growth potential.

The polypropylene segment is anticipated to see significant growth, growing at a CAGR of 7% and reach USD 633.9 million by 2034. Polypropylene (PP) is highly valued for its resistance to chemicals and high temperatures, making it ideal for use in high-stress environments such as cardiopulmonary bypass. Its stability at varying temperatures, alongside its biocompatibility, ensures it does not interfere with the body's natural processes. This material's ability to reduce thrombosis and inflammation during extracorporeal circulation is expected to drive the segment's growth.

The 100-200 mL segment is expected to grow at a CAGR of 6.9% to reach USD 869.2 million by 2034. These filters provide an optimal balance between filtration efficiency and hemodilution, making them suitable for adult surgeries. They are beneficial in preserving the patient's blood volume while reducing the need for donor blood transfusions. These filters have improved microbubble and air venting capabilities, which are essential for maintaining patient safety and ensuring high surgical standards. Their design minimizes blood flow resistance, further enhancing their demand in cardiac surgeries, particularly in adult cases, which dominate the global cardiac surgery market.

U.S. Arterial Filter Market accounted for USD 276.5 million in 2024. The country's advanced healthcare system and state-of-the-art surgical infrastructure have made it a key player in the arterial filter market. A highly trained medical workforce and a high volume of complex cardiac surgeries contribute to the ongoing demand for arterial filters in U.S. hospitals, driving the market's growth.

Prominent companies operating in the Global Arterial Filter Market include: Medtronic, GETINGE, SENKO Medical Instrument, Braile Biomedica, Pall Corporation, LivaNova, Lifeline Systems, EUROSETS, NIPRO, Gen World Medical Devices, TERUMO, and Beijing MEDOS AT Biotechnology. In the arterial filter market, companies are implementing several strategies to enhance their market position. They are focusing on the development of advanced, customized products that meet specific surgical needs, thereby differentiating their offerings. Additionally, many companies are investing in the research and development of materials that improve filter performance, such as biocompatible and hemocompatible options, to meet the growing demand for safer, more effective devices. Partnerships with hospitals and healthcare providers are also crucial, allowing manufacturers to integrate their filters into standard surgical practices.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Market scope and definitions
• 1.3 Research design
  • 1.3.1 Research approach
  • 1.3.2 Data collection methods
• 1.4 Data mining sources
  • 1.4.1 Global
  • 1.4.2 Regional/Country
• 1.5 Base estimates and calculations
  • 1.5.1 Base year calculation
  • 1.5.2 Key trends for market estimation
• 1.6 Primary research and validation
  • 1.6.1 Primary sources
• 1.7 Forecast model
• 1.8 Research assumptions and limitations

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis
• 2.2 Key market trends
  • 2.2.1 Regional trends
  • 2.2.2 Filter material trends
  • 2.2.3 Priming volume trends
  • 2.2.4 Age group trends
  • 2.2.5 Application trends
  • 2.2.6 End use trends
• 2.3 CXO perspectives: Strategic imperatives
  • 2.3.1 Key decision points for industry executives
  • 2.3.2 Critical success factors for market players

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence of cardiovascular diseases
    • 3.2.1.2 Growth in cardiopulmonary bypass procedures
    • 3.2.1.3 Technological advancements in filter design
    • 3.2.1.4 Rising geriatric population
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of cardiac surgeries and devices
    • 3.2.2.2 Risk of complications from filters
  • 3.2.3 Market opportunities
    • 3.2.3.1 Development of next-gen arterial filters
    • 3.2.3.2 Growth in pediatric and neonatal cardiac surgery
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 U.S.
  • 3.4.2 Europe
• 3.5 Technology landscape
• 3.6 Future market trends
• 3.7 Gap analysis
• 3.8 Porter's analysis
• 3.9 PESTEL analysis
• 3.10 Future market trends
• 3.11 Value chain analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
  • 4.3.1 By region
    • 4.3.1.1 North America
    • 4.3.1.2 Europe
    • 4.3.1.3 Asia Pacific
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard
• 4.7 Key developments
  • 4.7.1 Mergers and acquisitions
  • 4.7.2 Partnerships and collaborations
  • 4.7.3 New product launches
  • 4.7.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Filter Material, 2021 - 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Polypropylene
• 5.3 Polyethylene
• 5.4 Polyvinyl chloride (PVC)
• 5.5 Other filter materials

Chapter 6 Market Estimates and Forecast, By Priming Volume, 2021 - 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Less than 100 mL
• 6.3 100–200 mL
• 6.4 More than 200 mL

Chapter 7 Market Estimates and Forecast, By Age Group, 2021 - 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Adult
• 7.3 Neonatal/ pediatric

Chapter 8 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

• 8.1 Key trends
• 8.2 Cardiopulmonary bypass (CPB)
• 8.3 Extracorporeal membrane oxygenation (ECMO)
• 8.4 Other applications

Chapter 9 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

• 9.1 Key trends
• 9.2 Hospitals
• 9.3 Ambulatory surgical centers
• 9.4 Other end use

Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

• 10.1 Key trends
• 10.2 North America
  • 10.2.1 U.S.
  • 10.2.2 Canada
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 France
  • 10.3.4 Spain
  • 10.3.5 Italy
  • 10.3.6 Netherlands
• 10.4 Asia Pacific
  • 10.4.1 China
  • 10.4.2 Japan
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 South Korea
• 10.5 Latin America
  • 10.5.1 Brazil
  • 10.5.2 Mexico
  • 10.5.3 Argentina
• 10.6 Middle East and Africa
  • 10.6.1 South Africa
  • 10.6.2 Saudi Arabia
  • 10.6.3 UAE

Chapter 11 Company Profiles

• 11.1 Beijing MEDOS AT Biotechnology
• 11.2 Braile Biom'dica
• 11.3 EUROSETS
• 11.4 Gen World Medical Devices
• 11.5 GETINGE
• 11.6 Lifeline Systems
• 11.7 LivaNova
• 11.8 Medtronic
• 11.9 NIPRO
• 11.10 Pall Corporation
• 11.11 SENKO Medical Instrument
• 11.12 TERUMO